Pain News and Research

Latest Pain News and Research

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Roxane Laboratories, Inc. announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug Administration.

27 Jan 2010

Ablation therapy better than drug therapy for heart rhythm disorder

Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).

27 Jan 2010

Preoperative CT may help reduce unnecessary surgeries in women with suspected acute appendicitis

Preoperative computed tomography (CT) may help reduce unnecessary surgeries in women of reproductive age with suspected acute appendicitis, according to a new study appearing in the February issue of the journal Radiology.

27 Jan 2010

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.

27 Jan 2010

FDA approves oral pain relief solution for opioid-tolerant patients

The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.

27 Jan 2010

FDA approves Victoza to treat type 2 diabetes in some adults

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

27 Jan 2010

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Officials from 20 countries are meeting in Montreal, Canada, Monday "to discuss long-term reconstruction and arrangements for a donor conference to be held in March," the U.N. said, Bloomberg reports (Gaouette/Craze, 1/25). "U.S. Secretary of State Hillary Clinton, Canadian Prime Minister Stephen Harper, French Foreign Minister Bernard Kouchner and others will examine eventual debt forgiveness and" a strategy for rebuilding Haiti at the one-day gathering, according to Reuters (Palmer, 1/25).

27 Jan 2010

BioElectronics signs contract with YesDTC Holdings to enter the Japanese market

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the signing of a contract with YesDTC Holdings, Inc. (YESD.OB) to enter the Japanese market and receipt of the single largest product order and revenue commitment in company history.

26 Jan 2010

LTW Technologies' LED LIGHTWAVE therapy device receives 5 FDA clearances

LTW Technologies has received 5 FDA clearances (K082586) for its proprietary and unique multi-wavelength LED LIGHTWAVE therapy device. The LIGHTWAVE DELUXE series utilizes a revolutionary light therapy combination of Red light therapy, Blue light therapy and Infrared light therapy.

25 Jan 2010

Self-treatment for back pain: Sensory motor learning

Many people with back pain do not know what is causing it and they do not receive effective treatment, but learning to move in a more integrated way makes a big difference, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

Connecticut relief agencies join forces to deliver medical aid

Save the Children and AmeriCares have partnered to bring medical aid to more than 85,000 Haitians affected by the earthquake. Westport-based Save the Children's emergency response team in Haiti has distributed more than 16.5 tons of medical supplies in the town of Leogane and at the general hospital in Port-au-Prince – supplies donated by AmeriCares, the global health and disaster relief organization based in Stamford, Conn.

24 Jan 2010

Heart-healthy foods and activities for Valentine's Day

Heart disease is the leading cause of death for men and women nationwide so keep heart healthy foods, gifts and activities in mind this Valentine's Day.

23 Jan 2010

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

In an innovative new procedure, interventional cardiologist Ramesh Mazhari, MD, is one of only a few in the Washington, DC, region to access the coronary arteries through the radial artery on the inside of the wrist.

23 Jan 2010

Researchers set on grand challenge to accomplish targeted drug delivery for heart disease

Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.

23 Jan 2010

LA entrepreneur donates $1 million; launches Jenkins-Penn Haitian Relief Organization

Los Angeles entrepreneur Diana Jenkins today announced that she has donated $1 million and partnered with actor and director Sean Penn to establish the Jenkins-Penn Haitian Relief Organization to deliver medical supplies and transport doctors to people whose lives were devastated by the January 12 earthquake

23 Jan 2010

Health Care Freedom Act gains momentum

As the Obama Administration and the Washington D.C. forces pushing changes to American health care seek new alternatives in the wake of Scott Brown's game-changing victory in Massachusetts, one pathway to health care reform continues to gain momentum: the Health Care Freedom Act, modeled after the Arizona ballot initiative of the same name.

23 Jan 2010

Pfizer reports final results from randomized Phase 3 trial of Sutent

Pfizer Inc. today announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas.

23 Jan 2010

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.

23 Jan 2010

Heart murmurs in pediatric patients is not a serious condition, says physician

Your 3-year-old's doctor discovers a heart murmur during a visit for a mild cold with fever and recommends referral to a pediatric cardiologist. You worry and wonder how your healthy, active child could possibly have a heart problem.

23 Jan 2010

Ampyra receives FDA approval for improving walking in MS patients

The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

23 Jan 2010

Pain News and Research

Latest Pain News and Research

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Ablation therapy better than drug therapy for heart rhythm disorder

Preoperative CT may help reduce unnecessary surgeries in women with suspected acute appendicitis

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

FDA approves oral pain relief solution for opioid-tolerant patients

FDA approves Victoza to treat type 2 diabetes in some adults

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

BioElectronics signs contract with YesDTC Holdings to enter the Japanese market

LTW Technologies' LED LIGHTWAVE therapy device receives 5 FDA clearances

Self-treatment for back pain: Sensory motor learning

Connecticut relief agencies join forces to deliver medical aid

Heart-healthy foods and activities for Valentine's Day

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

Researchers set on grand challenge to accomplish targeted drug delivery for heart disease

LA entrepreneur donates $1 million; launches Jenkins-Penn Haitian Relief Organization

Health Care Freedom Act gains momentum

Pfizer reports final results from randomized Phase 3 trial of Sutent

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

Heart murmurs in pediatric patients is not a serious condition, says physician

Ampyra receives FDA approval for improving walking in MS patients

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in